Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults
- 29 October 1999
- Vol. 18 (7-8) , 641-646
- https://doi.org/10.1016/s0264-410x(99)00276-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Improved ELISA for determination of anti‐diphtheria and/or anti‐tetanus antitoxin antibodies in seraAPMIS, 1997
- Induction of Immunologic Memory in Gambian Children by Vaccination in Infancy with a Group A plus Group C Meningococcal Polysaccharide-Protein Conjugate VaccineThe Journal of Infectious Diseases, 1997
- Conjugate Meningococcal Serogroup A and C Vaccine: Reactogenicity and Immunogenicity in United Kingdom InfantsThe Journal of Infectious Diseases, 1996
- Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trialPublished by American Medical Association (AMA) ,1996
- Analysis of Meningococcal Serogroup C-Specific Antibody Levels in British Columbian Children and AdolescentsThe Journal of Infectious Diseases, 1996
- Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among childrenThe Journal of Pediatrics, 1996
- The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidisJAMA, 1995
- Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and CVaccine, 1992
- Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study GroupPublished by American Medical Association (AMA) ,1992
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969